We are live on ! Find out more
VSEEW

VSEE HEALTH INC WTS 29
VSEEW

Delisted

VSEEW was delisted on the 5th of August, 2026.

30 hedge funds and large institutions have $4.76M invested in VSEE HEALTH INC WTS 29 in 2022 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 4 increasing their positions, 2 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 2

12% less funds holding

Funds holding: 3430 (-4)

49% less capital invested

Capital invested by funds: $9.43M → $4.76M (-$4.66M)

80% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 5

Holders
30
Holders Change
-4
Holders Change %
-11.76%
% of All Funds
0.51%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
1
Increased
4
Reduced
2
Closed
5
Calls
$4K
Puts
Net Calls
+$4K
Net Calls Change
+$1K

VSEEW Hedge Fund Activity: Q3 2022 in Review

30 of the 5,829 institutional investors tracked by Wall St. Rank reported a position in VSEE HEALTH INC WTS 29 (VSEEW) for Q3 2022, worth a combined $4.76M — down 49% from $9.43M a quarter earlier.

Sellers outnumbered buyers: 5 funds closed out of VSEEW and 1 opened new positions — a net loss of 4 holders — while 2 trimmed existing stakes and 4 added.

The largest buyer was EHP Funds Inc, adding an estimated $56.5K. The largest seller was Mangrove Partners, exiting entirely with an estimated $5.01M sold.

  • 30 institutional investors held VSEE HEALTH INC WTS 29 (VSEEW) as of Q3 2022, down from 34 in Q2 2022.
  • Funds reported $4.76M of VSEE HEALTH INC WTS 29 stock for Q3 2022, down 49% quarter-over-quarter.
  • 1 fund opened new VSEE HEALTH INC WTS 29 positions in Q3 2022 and 5 closed out, a net change of -4 holders.
  • The largest VSEE HEALTH INC WTS 29 buyer in Q3 2022 was EHP Funds Inc, an estimated $56.5K added.
  • The largest VSEE HEALTH INC WTS 29 seller in Q3 2022 was Mangrove Partners, an estimated $5.01M sold.

Based on aggregated 13F filings for Q3 2022.